How Saudi investors found their way into an East Bay biotech targeting epilepsy
Hevolution ’s first Bay Area investment, in a Berkeley company, could help the company target Alzheimer's, Parkinson's and other neurodegenerative diseases.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Alzheimer's | Biotechnology | Brain | Epilepsy | Health Management | Middle East Health | Neurology | Parkinson's Disease | Pharmaceuticals | Saudi Arabia Health